101
trials. J Am Coll Cardiol 2011; 58(15):1569 – 1577.
38.
Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, Lilly RE, Sketch MH Jr., Peterson
ED, Jones RH. Selection of surgical or percutaneous coronary intervention provides differential
longevity benefit. Ann Thorac Surg 2006;82(4):1420 – 1428; discussion 1428 – 1429.
39.
Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RS, Carlson RE, Jones
RH. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl
J Med 2008;358(4):331 – 341.
40.
Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery.
Survival of patients with a low ejection fraction. N Engl J Med 1985; 312(26):1665 – 1671.
41.
Jones RH, Kesler K, Phillips HR 3rd, Mark DB, Smith PK, Nelson CL, Newman MF, Reves JG,
Anderson RW, Califf RM. Long-term survival benefits of coronary artery bypass grafting and
percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc
Surg 1996;111(5):1013 – 1025.
42.
Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure.
III. The role of revascularization in the treatment of patients with moderate or severe left ventricular
systolic dysfunction. JAMA 1994;272(19): 1528 – 1534.
43.
Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term
survival benefit associated with revascularization compared with medical
therapy in patients with no
prior coronary artery disease undergoing stress myocardial perfusion single photon emission
computed tomography. Circulation 2003;107(23):2900 – 2907.
44.
Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee
CW, Park SW, Chung CH, Lee JW, Lim DS, Rha SW, Lee SG, Gwon HC, Kim HS, Chae IH, Jang
Y, Jeong MH, Tahk SJ, Seung KB. Randomized trial of stents vs. bypass surgery for left main
coronary artery disease. N Engl J Med 2011;364(18):1718 – 1727.
45.
Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N, Bonser R, van den
Brand MJ, van Herwerden LA, Morel MA, van Hout BA. Comparison of coronary-artery bypass
surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344(15):1117 –
1124.
46.
Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, Golding LA, Gill
CC, Taylor PC, Sheldon WC et al. Influence of the internal-mammary-artery graft on 10-year survival
and other cardiac events. N Engl J Med 1986;314(1):1 – 6.
47.
Lytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FD, Cosgrove DM.
The effect of bilateral
internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg
2004;78(6):2005 – 2012; discussion 2012 – 2014.
48.
Taggart DP, Kaul S, Boden WE, Ferguson TB Jr., Guyton RA, Mack MJ, Sergeant PT, Shemin RJ,
Smith PK, Yusuf S. Revascularization for unprotected left main stem coronary artery stenosis stenting
or surgery. J Am Coll Cardiol 2008;51(9):885 – 892.
49.
Czer LS, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in sudden late death
by concomitant revascularization with aortic valve replacement. J Thorac Cardiovasc Surg
1988;95(3):390–401.
50.
Iung B, Drissi MF, Michel PL, de Pamphilis O, Tsezana R, Cormier B, Vahanian A, Acar J. Prognosis
of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a
comparative study. J Heart Valve Dis 1993;2(4):430 – 439.
51.
Lund O, Nielsen TT, Pilegaard HK, Magnussen K, Knudsen MA. The influence of coronary artery
disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J
Thorac Cardiovasc Surg 1990;100(3):327–337.
52.
DejaMA,GrayburnPA,SunB,RaoV,SheL,KrejcaM,JainAR,LengChuaY,DalyR, Senni M, Mokrzycki
K, Menicanti L, Oh JK, Michler R, Wrobel K, Lamy A,
Velazquez EJ, Lee KL, Jones RH. Influence
102
of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial.
Circulation 2012;125(21): 2639 – 2648.
53.
ChanKM,PunjabiPP,FlatherM,WageR,SymmondsK,RoussinI,Rahman-HaleyS, Pennell DJ, Kilner
PJ, Dreyfus GD, Pepper JR, Investigators R. Coronary artery bypass surgery with or without mitral
valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the
Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation 2012;126(21):2502–2510.
54.
TarakjiKG,SabikJF3rd,BhudiaSK,BatizyLH,BlackstoneEH.Temporalonset,risk
factors,
and
outcomes associated with stroke after coronary artery bypass grafting. JAMA 2011;305(4):381–390.
55.
Emmert MY, Seifert B, Wilhelm M, Grunenfelder J, Falk V, Salzberg SP.
Aortic no-touch technique
makes the difference in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg
2011;142(6):1499 – 1506.
56.
Misfeld M, Brereton RJ, Sweetman EA, Doig GS. Neurologic complications after off-pump coronary
artery bypass grafting with and without aortic manipulation: meta-analysis of 11,398 cases from 8
studies. J Thorac Cardiovasc Surg 2011; 142(2):e11 – e17.
57.
Bouchard D, Carrier M, Demers P, Cartier R, Pellerin M, Perrault LP, Lambert J. Statin in
combination with beta-blocker therapy reduces postoperative stroke after coronary artery bypass graft
surgery. Ann Thorac Surg 2011;91(3):654 – 659.
58.
Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, Cremonesi A, De Carlo
M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V,
Roffi M, Rother J, Sievert H, van Sambeek M, Zeller T. ESC Guidelines on the diagnosis and
treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial
carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the
Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).
Eur Heart J 2011;32(22):2851 – 2906.
59.
McFallsEO,WardHB,MoritzTE,GoldmanS,KrupskiWC,LittooyF,PierpontG, Santilli S, Rapp J,
Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG. Coronary-artery
revascularization before elective major vascular surgery. N Engl J Med 2004;351(27):2795 – 2804.
60.
Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK,
Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. 2009 ACCF/AHA focused update on
perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative
cardiovascular evaluation and care for noncardiac surgery: a report of the American college of
cardiology
foundation/American heart association task force on practice guidelines. Circulation
2009;120(21):e169 – e276.
463.
61.
Thielmann M, Massoudy P, Jaeger BR, Neuhauser M, Marggraf G, Sack S, Erbel R, Jakob H.
Emergency re-revascularization with percutaneous coronary intervention, reoperation, or
conservative treatment in patients with acute perioperative graft failure following coronary artery
bypass surgery. Eur J Cardiothorac Surg 2006;30(1):117 – 125.
62.
LaflammeM,DeMeyN,BouchardD,CarrierM,DemersP,PellerinM,CoutureP,
Perrault
LP.
Management of early postoperative coronary artery bypass graft failure. Interact Cardiovasc Thorac
Surg 2012;14(4):452–456.
63.
SubramanianS,SabikJF3rd,HoughtalingPL,NowickiER,BlackstoneEH,LytleBW. Decision-making
for patients with patent left internal thoracic artery grafts to left anterior descending. Ann Thorac Surg
2009;87(5):1392–1398; discussion 1400.
64.
DesaiND,CohenEA,NaylorCD,FremesSE,RadialArteryPatencyStudyI.Arandomized comparison of
radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med 2004;351(22):2302–2309.
65.
DebS,CohenEA,SinghSK,UneD,LaupacisA,FremesSE,InvestigatorsR.Radial artery and saphenous
vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial
Artery Patency Study). J Am Coll Cardiol 2012; 60(1):28 – 35.